{
  "docId": "019de074-d05c-76f7-9033-111a58abfc24",
  "docSlug": "ae35c14d996137506ca7741845086d60",
  "documentTitle": "argenx SE | Results Presentation Deck | 13 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 13,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a visual representation of an antibody to explain the mechanism of action (sweeping antibody, pH/Ca2+ switch, no effector function).",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de074-d05c-76f7-9033-111a58abfc24/6",
  "deckHref": "/decks/019de074-d05c-76f7-9033-111a58abfc24",
  "deckJsonHref": "/decks/019de074-d05c-76f7-9033-111a58abfc24.json",
  "deckAnchorHref": "/decks/019de074-d05c-76f7-9033-111a58abfc24#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.15,
        "x": 0.82,
        "y": 0.02
      },
      "kind": "callout",
      "text": "clinical Broaden immunology pipeline",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "553119f7-a28b-473c-b1c7-b8205b3e8259",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.05,
        "y": 0.38
      },
      "kind": "image",
      "text": "Antibody diagram showing sweeping mechanism",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "625459f4-facf-4640-a22f-5666c99c6727",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.5,
        "x": 0.35,
        "y": 0.35
      },
      "kind": "list",
      "text": "Confirm safety profile in MMN patients; Measure extent of complement blockade; Build PK/PD model; Confirm efficacy signal",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7a53259-deb2-485d-8fe9-134e56188149",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.35,
        "y": 0.75
      },
      "kind": "other",
      "text": "Dermatomyositis POC trial to start by end of 2023",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93d5decc-4209-4d28-997b-9f8a399cb90f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.67,
        "y": 0.75
      },
      "kind": "other",
      "text": "Delayed graft function in kidney transplant POC trial to start 2H23",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd36e29c-2163-4048-b706-ca55ca23667d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.68,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "ARGX-117: First Clinical Efficacy Data Expected Mid-2023",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b421895-99cf-4d07-a14f-aa9375148515",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Three-Act Structure",
      "slug": "three-act-structure",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "693ba4e1-8a45-4f3a-b0c4-927ca7a295a1",
      "evidence": "The slide presents a roadmap with specific milestones, indicating a structured approach to clinical trials.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 6,
      "beatId": "0567dec2-db9c-4fda-9a6a-91230daaa93f",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "What Could Be",
      "beatSlug": "sparkline-what-could-be-2",
      "evidence": "The roadmap and propose solution slides outline future plans and potential.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 4,
      "name": "Aha Moment",
      "slug": "03-aha-moment",
      "bestFor": "Data-heavy sections, research findings, analytical arguments",
      "matchId": "3e96dcc1-9c6f-4655-8b69-7e7bba613b4f",
      "evidence": "The key messages and roadmap slides highlight the company's innovative approach and upcoming milestones.",
      "position": 0,
      "objective": "What is the significance of argenx SE's progress in gMG treatment?",
      "structure": "The Problem/Question -> What the Data Shows -> The Insight",
      "confidence": 0.7,
      "description": "Establish a tension, present data, then deliver the insight that changes everything"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}